Key points from article :
Food and Drug administration approved a new treatment idea against coronavirus for human trials.
Treatment is derived from stem cells in human placentas.
Natural killer cells in the placenta protects a baby from viruses inside the mother while in her womb.
Plans to give infusions of this stem cell therapy to patients in order to get the same protection.
This early stage trial will include up to 86 coronavirus patients with symptoms.
This stem cell therapeutic approach was developed by New Jersey biotech company Celularity.
